Answers are grounded in this paper and cite their sources.
Experimental findings show tng260 enhances response rates to anti-pd-1 immunotherapy in stk11-mutant tumors, suggesting new treatment avenues.
Peptides that had significantly changed acetylation in response to treatment with either TNG260, entinostat, or vorinostat in pan-acetyl proteomics experiment
No takes yet. Share an insight, caveat, or question.
Ahronian et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: